Hypoallergenic Infant Formula for CMPA Market Analysis: Global Size Supposed to reach USD 12,541 MN in 2027 Hypoallergenic Infant Formula for CMPA Market Analysis: Global Size Supposed to reach USD 12,541 MN in 2027 January 16, 2021 | by admin | The latest market report published by Credence Research, Inc. “Global Hypoallergenic Infant Formula for CMPA Market: Growth, Future Prospects, and Competitive Analysis, 2019 – 2027”. The Hypoallergenic Infant Formula for CMPA market was valued at USS 5,096 million in 2020 and expected to grow at a CAGR of 12.7% during the forecast period from 2021 to 2027 to reach around USD 12,541 million in 2027. Hypoallergenic infant formula is typically manufactured in such a way that its boosts resistance in infants against any kind of allergies. This type of formula is highly prescribed for infants who have hereditary problem of critical allergies. There are generally five types of hypoallergenic infant formula which include extensively hydrolyzed formula, amino acid based elemental formula, soy-based formula, rice-based formula and others. Rising health related problem among infant is strengthening the demand for hypoallergenic formula among parents and is anticipated to bolster the market in future.